Transcervical Contraceptive Tubal Occlusion Device
Adverse-event figures are drawn from the U.S. Food & Drug Administration (FDA) MAUDE database, refreshed March 2026, see our methodology.
OpenFDA device adverse-event casebook.
FDA Class III (highest risk, premarket approval required), regulated under 21 CFR §884.5380 (Obstetrics/Gynecology panel).
FDA MAUDE casebook
openFDA event book Transcervical Contraceptive Tubal Occlusion… MID-BOOK · MAUDE
#52 of 1000 · 74,502 reports · 1994–2026
- BOOK 74,502 reports
- RANK #52 of 1000
- DEATH 137 death-typed
- INJ 72,854 injury-typed
- MALF 1,077 malfunction
- SPAN 1994–2026
- PEAK 2020: 16,135
- PHOTO Glucose Dehydrogenase
Nearest event-volume peer: Glucose Dehydrogenase, Glucose (297 report gap)
Transcervical Contraceptive Tubal Occlusion Device sits #52 of 1000 among tracked device types with 74,502 MAUDE reports spanning 1994–2026. Rank counts report volume, not confirmed device fault. Event_type Death / Injury / Malfunction are one code per report — not the same population as patient-outcome rows ( methodology). Read with this device → · Lead manufacturer → · Similar-volume device →
Injury-coded reports run above the device-type norm
Transcervical Contraceptive Tubal Occlusion… carries 97.8% INJURY-coded reports, 67.5pp above the 1,000-device-type mean, the widest gap of its three event codes. Codes are report labels, not adjudicated causation.
- DEATH 0.2% corpus 1.5% · below corpus mean (-1.3 pp)
- INJ 97.8% corpus 30.3% · above corpus mean (+67.5 pp)
- MALF 1.4% corpus 64.8% · below corpus mean (-63.4 pp)
Lead product-problem code Adverse Event Without Identified Device or Use Problem is 50% of coded problems · Lead manufacturer BAYER PHARMA AG accounts for 87% of manufacturer-tagged reports · Top event location I is 79% of location-tagged rows .
Transcervical Contraceptive Tubal Occlusion… in the event-volume neighbourhood
FDA MAUDE report totals among this device type and nearest nationwide peers
- Implant
Implant, Cochlear
75,024 reports
- Transcervical… (this)
Transcervical Contraceptive Tubal Occlusion Device
74,502 reports
- Glucose Dehyd…
Glucose Dehydrogenase, Glucose
74,205 reports
- Gastroscope A…
Gastroscope And Accessories, Flexible/Rigid
73,278 reports
- Set
Set, Administration, For Peritoneal Dialysis, Disposable
72,142 reports
- System
System, Endovascular Graft, Aortic Aneurysm Treatment
71,804 reports
What this shows Transcervical Contraceptive Tubal Occlusion Device carries 74,502 MAUDE reports, ranked #52 of 1000.
Event Types
Patient Outcomes
FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.
Top Product Problems
Yearly Trend
Reports fell to 756 in 2025, down from an average of 2,243 in the two years before.
Related Entities for Transcervical Contraceptive Tubal Occlusion Device
Top Manufacturers
Event Locations
Nationwide devices with a comparable volume-and-death footprint
Two openFDA-derived peer sets for Transcervical Contraceptive Tubal Occlusion…: nearest by total report volume and nearest by death-typed count, each floored at ≥100 reports so the neighborhoods stay in the advertised mass.
Similar report volume
Nearest other device types by FDA MAUDE report count (74,502 here).
Similar death-typed counts
Nearest other device types by death-typed report count (137 here), distinct from the volume row.
Read our methodology - how this data is sourced, computed, and verified.
Disclaimer: MAUDE figures for Transcervical Contraceptive Tubal Occlusion… are informational only and are not clinical advice. Report codes do not prove device causation. Consult a qualified clinician before acting on this data.
Every figure on PlainHospital is rendered directly from federal source data, no number is typed in by an editor. Event-type mix on this page is computed from FDA MAUDE codes for Transcervical Contraceptive Tubal Occlusion…; corpus means use device types with ≥100 reports. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.